| Expression pattern: |
DN |
| Associated gene: |
PDCD4, AKT, PI3K/AKT signaling pathway, AGO2 |
| Associated microRNA: |
miR-330-3p |
| Biological function: |
inhibits proliferation; inhibits migration; inhibits invasion; suppresses tumor growth |
| Molecular mechanism: |
Encodes SEMA4B-211aa via IRES-dependent translation and acts as a miRNA sponge (miR-330-3p) to upregulate PDCD4, inhibiting AKT phosphorylation (Ser473) and PI3K/AKT signaling. |
| Biological pathway or process: |
PI3K/AKT (inhibits); proliferation (inhibits); migration (inhibits); invasion (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; MTT; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Western Blot; Co-IP; GST pull-down assay; ELISA; In Vivo Animal Model; IHC (Immunohistochemistry) |
| Clinical significance: |
Low expression of circSEMA4B was positively associated with TNM stage, tumor size, lymph node metastasis, recurrence, and metastasis. |
| Description: |
circSEMA4B is down-regulated in breast cancer and functions as a tumor suppressor. It inhibits PI3K/AKT signaling by sponging miR-330-3p to upregulate PDCD4 (reducing AKT Ser473 phosphorylation) and also serves as a protein-coding circRNA that produces SEMA4B-211aa, which contributes to pathway suppression. |
| Confidence score: |
0.8752 |